Trial Profile
Effect of actonel [risedronic acid] on periodontal health of postmenopausal women.
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase IV
Latest Information Update: 21 Jul 2022
Price :
$35
*
At a glance
- Drugs Risedronic acid (Primary)
- Indications Metabolic bone diseases
- Focus Pharmacodynamics
- 14 Jul 2022 Status changed from recruiting to withdrawn prior to enrolment.